Benzinga's Top Upgrades, Downgrades For July 14, 2017

Top Upgrades

  • Analysts at JP Morgan upgraded Boeing Co BA from Neutral to Overweight. Boeing shares rose 0.83 percent to $207.94 in pre-market trading.
  • Needham upgraded Cornerstone OnDemand, Inc. CSOD from Buy to Strong Buy. Cornerstone OnDemand shares gained 1.06 percent to $37.10 in pre-market trading.
  • JP Morgan upgraded HD Supply Holdings Inc HDS from Neutral to Overweight. HD Supply shares rose 2.55 percent to close at $30.21 on Thursday.
  • Analysts at Telsey Advisory Group upgraded Ross Stores, Inc. ROST from Market Perform to Outperform. Ross Stores shares rose 1.07 percent to $55.00 in pre-market trading.
  • Analysts at Goldman Sachs upgraded Ulta Beauty Inc ULTA from Neutral to Conviction Buy. Ulta Beauty shares rose 1.47 percent to $261.18 in pre-market trading.
  • Goldman Sachs upgraded Wal-Mart Stores Inc WMT from Neutral to Conviction Buy. Wal-Mart shares gained 1.60 percent to $76.25 in pre-market trading.
  • Canaccord Genuity upgraded BJ's Restaurants, Inc. BJRI from Hold to Buy. BJ's Restaurants shares fell 2.07 percent to close at $35.40 on Thursday.
  • Analysts at KeyBanc upgraded Magellan Health Inc MGLN from Sector Weight to Overweight. Magellan Health shares climbed 6.01 percent to close at $77.65 on Thursday.


Top Downgrades

  • Piper Jaffray downgraded F5 Networks, Inc. FFIV from Overweight to Neutral. F5 Networks shares fell 3.34 percent to $124.00 in after-hours trading.
  • JP Morgan downgraded Cyberark Software Ltd CYBR from Overweight to Neutral. CyberArk shares dropped 19.80 percent to $40.90 in pre-market trading.
  • KeyBanc downgraded A10 Networks Inc ATEN from Overweight to Sector Weight. A10 Networks shares fell 16.87 percent to $6.85 in pre-market trading.
  • Analysts at Deutsche Bank downgraded East West Bancorp, Inc. EWBC from Buy to Hold. East West Bancorp shares rose 0.34 percent to close at $58.46 on Thursday.
  • Analysts at Cowen & Co. downgraded Snap Inc SNAP from Outperform to Market Perform. Snap shares fell 2.17 percent to $15.35 in pre-market trading.
  • Goldman Sachs downgraded At Home Group Inc HOME from Buy to Neutral. At Home shares gained 0.86 percent to close at $23.48 on Thursday.
  • Oppenheimer downgraded Himax Technologies, Inc. (ADR) HIMX from Perform to Underperform. Himax Technologies shares fell 4.87 percent to $7.62 in pre-market trading.
  • SunTrust Robinson Humphrey downgraded Kratos Defense & Security Solutions, Inc KTOS from Buy to Hold. Kratos Defense shares dropped 3.65 percent to $12.40 in pre-market trading.
  • Bank of America downgraded Avnet, Inc. AVT from Neutral to Underperform. Avnet shares fell 1.13 percent to $39.34 in pre-market trading.
  • Raymond James downgraded Summit Hotel Properties Inc INN from Outperform to Market Perform. Summit Hotel Properties shares dropped 0.27 percent to close at $18.21 on Thursday.


Top Initiations

  • BTIG Research initiated coverage of Eiger Biopharmaceuticals Inc EIGR with a Buy rating. The price target for Eiger Biopharmaceuticals is set to $32. Eiger Biopharmaceuticals shares closed at $7.45 on Thursday.
  • Analysts at CL King initiated coverage on Neogen Corporation NEOG with a Neutral rating. Neogen shares closed at $68.05 on Thursday.
  • Oppenheimer initiated coverage on Woodward Inc WWD with an Outperform rating. The price target for Woodward is set to 82. Woodward shares closed at $67.48 on Thursday.
  • SunTrust Robinson Humphrey initiated coverage on Affimed NV AFMD with a Buy rating. The price target for Affimed is set to $7. Affimed shares closed at $2.40 on Thursday.
  • Analysts at Rosenblatt initiated coverage on News Corp NWSA with a Buy rating. The price target for News Corp is set to $17. News Corp shares closed at $13.23 on Thursday.
  • Analysts at JP Morgan initiated coverage on The GEO Group Inc GEO with an Overweight rating. The price target for GEO Group is set to $35. GEO Group shares closed at $29.93 on Thursday.
  • Janney Capital initiated coverage on Supernus Pharmaceuticals Inc SUPN with a Neutral rating. The price target for Supernus Pharmaceuticals is set to $47. Supernus Pharmaceuticals shares closed at $44.05 on Thursday.
  • SunTrust Robinson Humphrey initiated coverage on Editas Medicine Inc EDIT with a Hold rating. The price target for Editas Medicine is set to $17. Editas Medicine shares closed at $17.71 on Thursday.

Posted In: DowngradesInitiationstop upgradesUpgradesDowngradesInitiationAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.